ETRACS 2x Leveraged US Growth Factor TR ETN
IWFL
1 hedge funds and large institutions have $15K invested in ETRACS 2x Leveraged US Growth Factor TR ETN in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
400% more capital invested
Capital invested by funds: $3K → $15K (+$12K)
0.08% more ownership
Funds ownership: 0.02% → 0.09% (+0.08%)
0% more funds holding
Funds holding: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$15.1K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $15K | +$15.1K | +765 | +497% |
|
IWFL Hedge Fund Activity: Q3 2022 in Review
1 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) for Q3 2022, worth a combined $15K — up 400% from $3K a quarter earlier.
Fund positioning in IWFL was balanced in Q3 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $15.1K.
- 1 institutional investor held ETRACS 2x Leveraged US Growth Factor TR ETN (IWFL) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $15K of ETRACS 2x Leveraged US Growth Factor TR ETN stock for Q3 2022, up 400% quarter-over-quarter.
- 0 funds opened new ETRACS 2x Leveraged US Growth Factor TR ETN positions in Q3 2022 and 0 closed out.
- The largest ETRACS 2x Leveraged US Growth Factor TR ETN buyer in Q3 2022 was UBS Group, an estimated $15.1K added.
Based on aggregated 13F filings for Q3 2022.